NGVT

In the past six months, CEO Dave Li and CFO Phil Platt have engaged in executive appearances at industry conferences to discuss the company's strategy and financial outlook. Ingevity reported its Q2 2026 financial results on July 29, 2026, with adjusted earnings increasing and net sales declining, and an EPS of $1.74 which exceeded consensus estimates. The company has been actively optimizing its portfolio through divestitures, including the sale of its North Charleston crude tall oil refinery assets and most of its Performance Chemicals Industrial Specialties product line on January 1, 2026, and the sale of Ozark Materials LLC to PPG on April 15, 2026, to focus on core businesses. Several executives, including CEO David H. Li, SVP Ryan C. Fisher, and CFO Phillip John Platt, have sold company stock in recent months. As of September 21, 2026, Ingevity's stock closed at $68.96, having gained 22.4% over the past 12 months, with a 52-week range between $45.85 and $79.29. Analysts currently hold a consensus 'Hold' rating for Ingevity, with an average price target of $80.00, indicating a potential upside of approximately 16.7%.